The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

NCT06243536 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Overweight
Disordered Eating Behaviors

Interventions

DRUG: Semaglutide
DRUG: standard of care

Sponsor

University Hospital Sestre Milosrdnice

Collaborators

[object Object]